GTCM
PFE icon

Gyon Technologies Capital Management’s Pfizer PFE Stock Holding History

Gyon Technologies Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,952
Closed -$411K – 493
2021
Q4 		$411K Buy
6,952
+998
+17% +$49.4K 0.08% 352
2021
Q3 		$256K Sell
5,954
-75,572
-93% -$3.35M 0.07% 317
2021
Q2 		$3.19M Buy
81,526
+53,702
+193% +$2.09M 1.05% 6
2021
Q1 		$1.01M Buy
27,824
+20,774
+295% +$738K 0.44% 47
2020
Q4 		$260K Sell
7,050
-681
-9% -$25K 0.09% 269
2020
Q3 		$269K Buy
+7,731
New +$271K 0.21% 172
2020
Q2 		– Sell
-27,828
Closed -$862K – 131
2020
Q1 		$862K Buy
+27,828
New +$948K 1.66% 17

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gyon Technologies Capital Management's PFE Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 6,952 shares — an estimated $411K sold.

Gyon Technologies Capital Management first reported a position in PFE in Q1 2020 and held it in 7 quarters. The position peaked at $3.19M in Q2 2021. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Gyon Technologies Capital Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 6,952 Pfizer shares in Q1 2022, an estimated $411K.
  • Gyon Technologies Capital Management first reported a position in Pfizer in Q1 2020 and held it in 7 quarters.
  • Gyon Technologies Capital Management's Pfizer position peaked at $3.19M in Q2 2021.
  • 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.